The effectiveness of anti-osteoporotic therapy with alendronate in geriatric hip fracture patients

To evaluate the difference of bone mineral density and serum concentration of osteocalcin, CTX in geriatric hip fracture patients after 12 months of anti-osteoporotic therapy with alendronate.